Valeant Pharma VRX shares are trading lower by $4.23 at $93.63 in Wednesday's session. Off the open, it failed to reach triple digits on an intraday basis for the first time since September 13, 2013, when it peaked at $99.50. Since making the high, it has declined to $92.29 and has not been about to mount much of a rally. There is one daily support level ahead of the low for the recent down move. That stands at its October 30 low ($90.46)
Joel Elconin is the co-host of Benzinga;s #PreMarket Prep, a daily trading idea radio show.
Do you like this article? Do you have suggestions for improvement? Please email feedback@benzinga.com.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in